申请人:Plexxikon Inc.
公开号:US20180215763A1
公开(公告)日:2018-08-02
Disclosed are compounds of Formula I:
or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein R
4
, X
3
, X
4
, X
5
, X
6
, X
7
and Ring A are as described in any of the embodiments described in this disclosure; compositions thereof; and uses thereof.